SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
The Significance of Prenuptial Arrangements in Separation Procedures - 2Flu is rising rapidly, driven by a new variant. Here's what to know
- 3Why ordering takeout or calling the dog walker might lead to a happier relationship
- 4The most effective method to Make a Dazzling Site in 5 Basic Advances
- 5Wisconsin judge sends Slender Man attacker back to mental health institution after group home escape
- Displaced Palestinian families suffer as heavy rains flood Gaza tent camps
- New movies to watch this weekend: See 'Wake Up Dead Man: A Knives Out Mystery' in theaters, rent 'Bugonia,' stream 'Caught Stealing' on Netflix
- Birds at a college changed beak shapes during the pandemic. It might be a case of rapid evolution
- The most effective method to Remain Ahead in the Most recent Advanced Patterns with a Web based Advertising Degree
- Most loved Public Dish: Which One Addresses Its Nation Best?
- Full Supreme Court to hear challenge to Judicial Selection Committee law
- With more Moon missions on the horizon, avoiding crowding and collisions will be a growing challenge
- Manual for Vegetarian Protein Powder
- FDA proposes use of sunscreen ingredient popular in other countries
